HMGCR and ovarian carcinoma: One study examined the risk of developing epithelial ovarian cancer in patients with genetically proxied inhibition of HMG-CoA reductase caused by a single nucleotide polymorphism in a gene associated with reduced functionality of HMG-CoA reductase.